IBDEI1M0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,27304,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,27304,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,27305,0)
 ;;=E10.65^^106^1348^6
 ;;^UTILITY(U,$J,358.3,27305,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27305,1,3,0)
 ;;=3^Diabetes Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,27305,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,27305,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,27306,0)
 ;;=E11.21^^106^1348^9
 ;;^UTILITY(U,$J,358.3,27306,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27306,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,27306,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,27306,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,27307,0)
 ;;=E10.29^^106^1348^3
 ;;^UTILITY(U,$J,358.3,27307,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27307,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Kidney Complication
 ;;^UTILITY(U,$J,358.3,27307,1,4,0)
 ;;=4^E10.29
 ;;^UTILITY(U,$J,358.3,27307,2)
 ;;=^5002591
 ;;^UTILITY(U,$J,358.3,27308,0)
 ;;=E10.21^^106^1348^4
 ;;^UTILITY(U,$J,358.3,27308,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27308,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Nephropathy
 ;;^UTILITY(U,$J,358.3,27308,1,4,0)
 ;;=4^E10.21
 ;;^UTILITY(U,$J,358.3,27308,2)
 ;;=^5002589
 ;;^UTILITY(U,$J,358.3,27309,0)
 ;;=E11.40^^106^1348^10
 ;;^UTILITY(U,$J,358.3,27309,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27309,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,27309,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,27309,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,27310,0)
 ;;=E10.40^^106^1348^5
 ;;^UTILITY(U,$J,358.3,27310,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27310,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic Neuropathy
 ;;^UTILITY(U,$J,358.3,27310,1,4,0)
 ;;=4^E10.40
 ;;^UTILITY(U,$J,358.3,27310,2)
 ;;=^5002604
 ;;^UTILITY(U,$J,358.3,27311,0)
 ;;=E10.22^^106^1348^2
 ;;^UTILITY(U,$J,358.3,27311,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27311,1,3,0)
 ;;=3^Diabetes Type 1 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,27311,1,4,0)
 ;;=4^E10.22
 ;;^UTILITY(U,$J,358.3,27311,2)
 ;;=^5002590
 ;;^UTILITY(U,$J,358.3,27312,0)
 ;;=E10.9^^106^1348^7
 ;;^UTILITY(U,$J,358.3,27312,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27312,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,27312,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,27312,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,27313,0)
 ;;=E11.22^^106^1348^8
 ;;^UTILITY(U,$J,358.3,27313,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27313,1,3,0)
 ;;=3^Diabetes Type 2 w/ Diabetic CKD
 ;;^UTILITY(U,$J,358.3,27313,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,27313,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,27314,0)
 ;;=E11.9^^106^1348^12
 ;;^UTILITY(U,$J,358.3,27314,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27314,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,27314,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,27314,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,27315,0)
 ;;=E13.22^^106^1348^1
 ;;^UTILITY(U,$J,358.3,27315,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27315,1,3,0)
 ;;=3^DM w/ Diabetic CKD,Other
 ;;^UTILITY(U,$J,358.3,27315,1,4,0)
 ;;=4^E13.22
 ;;^UTILITY(U,$J,358.3,27315,2)
 ;;=^5002671
 ;;^UTILITY(U,$J,358.3,27316,0)
 ;;=E83.30^^106^1349^26
 ;;^UTILITY(U,$J,358.3,27316,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27316,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,27316,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,27316,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,27317,0)
 ;;=E83.31^^106^1349^9
 ;;^UTILITY(U,$J,358.3,27317,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,27317,1,3,0)
 ;;=3^Familial Hypophosphatemia
